Home › Upcoming votes › BioLife Solutions, Inc.
This meeting took place on October 5, 2026. BioLife Solutions, Inc. reported the official results on Form 8-K, filed October 6, 2026 (read it on EDGAR); they are listed below. How funds voted appears on the company page after funds file Form N-PX, by August 31 after the proxy season ends on June 30.
The deadline as the proxy statement states it: “voting instructions up until 11:59 p.m. Eastern Daylight Time on October 4, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGARBioLife Solutions, Inc.: past votes
Ballot read from the proxy statement and checked. As listed in BioLife Solutions, Inc.’s proxy statement, with the board’s recommendation on each item. The company has filed 2 sets of additional materials since; they can add to or change what is below, so check them before relying on it.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | ADOPTION OF THE MERGER AGREEMENT | Board | For | — |
| 2 | (NON-BINDING) VOTE ON MERGER-RELATED COMPENSATION FOR NAMED EXECUTIVE OFFICERS Say on pay |
Board | For | 95% support |
| 3 | Adjournment of the BioLife Special Adjournment |
Board | For | — |
From BioLife Solutions, Inc.’s Form 8-K, filed August 21, 2025, for the meeting held August 20, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Roderick de Greef | 98% | — |
| Elect Director: Catherine Coste | 99.7% | Elected |
| Elect Director: Amy DuRoss | 98% | Elected |
| Elect Director: Rachel Ellingson | 51.1% | Elected |
| Elect Director: Joydeep Goswami | 57% | Elected |
| Elect Director: Tony Hunt | 97% | Elected |
| Elect Director: Timothy Moore | 99% | Elected |
| 2. Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers | 95% | Approved |
| 3. Ratification of the appointment by the Audit Committee of Grant Thornton LLP as the Company's independent registered public accounting fi | 99.9% | Approved |
The five managers that reported the most shares voted at BioLife Solutions, Inc.’s August 20, 2025 meeting, from their Form N-PX filings. This is how they voted then; it says nothing about how they will vote this time. Every manager’s vote.
| Item | T. Rowe Price | Casdin Capital, LLC | Invesco | BlackRock | Vanguard |
|---|---|---|---|---|---|
| Elect Director: Roderick de Greef | For | — | For | For | For |
| Elect Director: Catherine Coste | For | — | For | For | For |
| Elect Director: Amy DuRoss | For | — | For | For | For |
| Elect Director: Rachel Ellingson | Withhold | — | Withhold | For | For |
| Elect Director: Joydeep Goswami | Withhold | — | For | For | For |
| Elect Director: Tony Hunt | For | — | For | For | For |
| Elect Director: Timothy Moore | For | — | For | For | For |
| 2. Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers | For | For | For | For | For |
| 3. Ratification of the appointment by the Audit Committee of Grant Thornton LLP as the Company's independent registered | For | — | For | For | For |
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| 1. Adoption of the Merger Agreement: The stockholders of BioLife adopted the Merger Agreement, pursuant to which Repligen acquired BioLife v | 99.7% | — |
| 2. Advisory Vote (Non-binding) Vote on Merger-Related Compensation for Named Executive Officers: The stockholders of BioLife approved, on an | 86% | — |
| 3. Adjournment of the Special Meeting: The stockholders of BioLife approved a proposal to adjourn the Special Meeting to a later date or dat | 86% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.